ACCRUED EXPENSES

9 Months Ended

Sep. 30, 2024

Payables and Accruals [Abstract]

ACCRUED EXPENSES

9. ACCRUED EXPENSES

The following table summarizes the Company’s accrued expenses for each of the periods indicated:

	As of September 30, 2024		As of December 31, 2023
	(in thousands)
Product revenue related reserves	$	108,721	$	100,075
Accrued contract manufacturing costs		75,909		33,024
Accrued employee compensation costs		57,107		78,732
Accrued clinical and pre-clinical costs		40,514		34,669
Accrued professional fees		21,486		17,187
Accrued income taxes		14,696		13,766
Accrued royalties		12,185		12,070
Accrued fixed assets		4,821		3,231
Accrued research expenses		2,882		2,441
Accrued interest		1,118		4,395
Other		5,391		15,407
Total accrued expenses	$	344,830	$	314,997